One of the earliest proposed targets for gene editing to treat or cure HIV infection was CCR5, a nonessential G-protein coupled chemokine receptor, which is also the most common co-receptor for entry used by HIV after binding CD4 [240]. The gene discussed is CCR5; the disease is HIV infectious disease.